HHealthcare Read More Fat-loss drug Mounjaro now India’s No. 2 pharma brand | India NewsOctober 8, 2025 NEW DELHI: Soaring demand for weight-loss therapies has brought Eli Lilly’s Mounjaro within striking distance of Indian pharma…
HHealthcare Read More Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors sayOctober 4, 2025 By Nancy Lapid (Reuters) -Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs should be the first medicines doctors…
HHealthcare Read More Novo, Lilly weight-loss drugs should be first option obesity treatments, European doctors sayOctober 4, 2025 By Nancy Lapid (Reuters) -Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs should be the first medicines doctors…
HHealthcare Read More 1 Reason Novo Nordisk (NVO) Is 1 of the Best Healthcare Stocks You Can Buy TodaySeptember 30, 2025 Novo Nordisk is leading the race to get an oral weight loss GLP-1 drug approved. It needs to…
MMarkets Read More Wall Street rises to its first gain in 4 daysSeptember 26, 2025 NEW YORK (AP) — U.S. stocks climbed Friday and trimmed their losses for the week after a report…
MMedication Read More How the ‘Ozempic effect’ is reshaping the global economySeptember 12, 2025 Michael Siluk/Alamy The new wave of weight-loss drugs has taken the world by storm. From Novo Nordisk’s Ozempic…
MMedication Read More Wegovy And Zepbound Cost Effective But They Could Break Drug BudgetsSeptember 11, 2025 The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative…
HHealthcare Read More Weight-loss drugs becoming better value for money, says watchdogSeptember 10, 2025 Popular GLP-1 weight-loss injections are now delivering greater value, according to a new report by a leading pharmaceutical…